“biosimilars” Archives

Entry Author Date Location
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
Biopharmaceutical Haiku 02/03/14 National
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
San Diego Life Sciences Roundup: Life’s M&A Deal, Santarus, & More 04/18/13 San Diego
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 12/27/11 New York
Momenta, Baxter Team Up on Biosimilars 12/23/11 Boston
Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines 12/23/11 Boston
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs 12/19/11 National
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
Biogen Idec Boosts Biogenerics Strategy With $300M Samsung Joint Venture 12/06/11 Boston
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom 10/05/11 New York
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare 05/20/11 New York
Pfenex Launches Reagent Proteins Business 11/02/10 San Diego
Where Will the New Disease Treatments Come From a Decade From Now? 07/15/10 San Francisco
Alnylam Eyes RNAi for Manufacturing Drugs 11/12/09 Boston
DC Matters, But Biotech Can’t Neglect City Hall 10/07/09 Seattle
Protecting America’s Leadership in Biotech Discovery 08/06/09 Seattle
How Healthcare Legislation Can Ensure Patient Safety and Spur Innovation 07/09/09 Seattle
Biocom or Biopol? San Diego’s Life Sciences Trade Group Aims to Build California Clout in D.C 01/28/09 San Diego
Page 1 of 1